Abstract
22q11.2 Deletion Syndrome (22q11.2DS) is a common microdeletion syndrome with multisystem features. There is a strong association with psychiatric disorders. One in every four to five patients develop schizophrenia. Despite studies showing that early diagnosis and treatment are likely to lead to improved outcome, genetic counselors may be reluctant to discuss the risk of psychiatric illness. The aim of this research was to explore parental attitudes and genetic counselors’ perspectives and practice regarding disclosure of the clinical manifestations of 22q11.2DS, particularly the risk of psychiatric illness. We delivered a questionnaire to genetic counselors via established list-serves, 54 of which were completed. We also conducted interviews with four parents of adults with 22q11.2DS and schizophrenia. The majority of counselors and parents felt that the increased risk to develop a psychiatric illness is important to disclose. However, in the initial counseling session when the diagnosis was made in infancy genetic counselors were significantly less likely to discuss the risk of psychiatric disorders compared to other later onset features such as hypothyroidism (41 % vs. 83 %, p = 0.001). When the diagnosis of 22q11.2DS was made in infancy, counselors’ responses in regard to timing of disclosure about psychiatric illnesses were fairly evenly divided between infancy, childhood and adolescence. In contrast, for other major features of 22q11.2DS, disclosure would predominantly be in infancy. The respondents reported that the discussion of psychiatric issues with parents was challenging due to the stigma associated with mental illness. Some also noted limited knowledge about psychiatric illness and treatment. These results suggest that genetic counselors could benefit from further education regarding psychiatric illness in 22q11.2DS and best strategies for discussing this important subject with parents and patients.
Similar content being viewed by others
References
Antshel, K. M., Shprintzen, R., Fremont, W., Higgins, A. M., Faraone, S. V., & Kates, W. R. (2010). Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 333–344.
Bassett, A. S., Chow, E. W., Husted, J., Weksberg, R., Caluseriu, O., Webb, G. D., & Gatzoulis, M. A. (2005). Clinical features of 78 adults with 22q11 Deletion Syndrome. American Journal of Medical Genetics Part A, 138, 307–313.
Bassett, A. S., & Chow, E. W. C. (2008). Schizophrenia and 22q11.2 deletion syndrome. Current Psychiatry Reports, 10, 148–157.
Bassett, A. S., Chow, E. W. C., & Hodgkinson, K. A. (2008a). Genetics of schizophrenia and psychotic disorders. In J. W. Smoller, B. R. Sheidley, & M. T. Tsuang (Eds.), Psychiatric genetics: Applications in clinical practice (pp. 99–130). Washington, DC: American Psychiatric Publishing.
Bassett, A. S., Marshall, C. R., Lionel, A. C., Chow, E. W., & Scherer, S. W. (2008b). Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Human Molecular Genetics, 17, 4045–4053.
Bassett, A. S., McDonald-McGinn, D. M., Devriendt, K., Digilio, M. C., Goldenberg, P., Habel, et al. (2011). Practical guidelines for managing patients with 22q11.2 deletion syndrome. Journal of Pediatrics, 159, 332–339.
Botto, L. D., May, K., Fernhoff, P. M., Correa, A., Coleman, K., Rasmussen, S. A., et al. (2003). A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics, 112, 101–107.
Costain, G., Chow, E. W., Ray, P. N., & Bassett, A. S. (2011a). Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. Journal of Intellectual Disability Resesearch (e published)
Costain, G., Chow, E. W. C., Silversides, C. K., & Bassett, A. S. (2011b). Sex differences in reproductive fitness contribute to preferential maternal transmission of 22q11.2 deletions. Journal of Medical Genetics, 48, 819–824.
Diekelmann, N. (1992). Learning-As-Testing: a Heideggerian Hereneutical analysis of the lived experiences of students and teachers in nursing. Advances in Nursing Science, 14, 72–83.
Drew, L. J., Crabtree, G. W., Markx, S., Stark, K. L., Chaverneff, F., Xu, B., et al. (2011). The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. International Journal of Developmental Neuroscience, 29, 259–281.
Emanuel, B. S. (2008). Molecular mechanisms and diagnosis of chromosome 22q11.2 rearrangements. Developmental Disabilities Research Reviews, 14, 11–18.
Feder, A., Nestler, E. J., & Charney, D. S. (2009). Psychobiology and molecular genetics of resilience. Nature Reviews Neuroscience, 10, 446–57.
Feret, H., Conway, L., & Austin, J. C. (2011). Genetic counselors’ attitudes towards individuals with schizophrenia: desire for social distance and endorsement of stereotypes. Patient Education and Counseling, 82, 69–73.
Fung, W. L. A., McEvilly, R., Fong, J., Silversides, C., Chow, E., & Bassett, A. S. (2010). Elevated prevalence of generalized anxiety disorder in adults with 22q11.2 deletion syndrome. American Journal of Psychiatry, 167, 998.
Goldberg, R., Motzkin, B., Marion, R., Scambler, P. J., & Shprintzen, R. J. (1993). Velo-cardio-facial syndrome: a review of 120 patients. American Journal of Medical Genetics, 45, 313–319.
Hasnat, M. J., & Graves, P. (2000). Disclosure of developmental disability: a study of parent satisfaction and the determinants of satisfaction. Journal of Paediatrics and Child Health, 36, 32–35.
Hercher, L., & Bruenner, G. (2008). Living with a child at risk for psychotic illness: the experience of parents coping with 22q11 deletion syndrome: an exploratory study. American Journal of Medical Geneics Part A, 146A, 2355–2360.
Hodgkinson, K. A., Murphy, J., O’Neill, S., Brzustowicz, L., & Bassett, A. S. (2001). Genetic counselling for schizophrenia in the era of molecular genetics. Canadian Journal of Psychiatry, 46, 123–130.
Kobrynski, L. J., & Sullivan, K. E. (2007). Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet, 370, 1443–1452.
Mann, C. E., & Himelein, M. J. (2004). Factors associated with stigmatization of persons with mental illness. Psychiatric Services, 55, 185–187.
McDonald-McGinn, D. M., Tonnesen, M. K., Laufer-Cahana, A., Finucane, B., Driscoll, D. A., Emanuel, B. S., et al. (2001). Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genetics in Medicine, 3, 23–29.
Murphy, K. C., Jones, L. A., & Owen, M. J. (1999). High rates of schizophrenia in adults with velo-cardio-facial syndrome. Archives of General Psychiatry, 56, 940–945.
Peay, H., & McInerney, J. (2002). A pilot study on psychiatric genetic counselling: counselor’s needs. Journal of Genetic Counseling, 11, 485. (Abstract)
Pain, H. (1999). Coping with a child with disabilities from the parents’ perspective: the function of information. Child: Care, Health and Development, 25, 299–312.
Philip, N., & Bassett, A. S. (2011). Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome. Behavior Genetics, 41, 403–412.
Pulver, A. E., Nestadt, G., Goldberg, R., Shprintzen, R. J., Lamacz, M., Wolyniec, P. S., et al. (1994). Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. Journal of Nervous and Mental Disorders, 182, 476–478.
Reavley, N. J., & Jorm, A. F. (2011). Stigmatizing attitudes towards people with mental disorders: findings from an Australian National Survey of Mental Health Literacy and Stigma. Australian and New Zealand Journal of Psychiatry, 45, 1086–1093.
Sloper, P., & Turner, S. (1993). Determinants of parental satisfaction with disclosure of disability. Developmental Medicine and Child Neurology, 35, 816–825.
Sykes, K. S., Bachrach, L. K., Siegel-Bartelt, J., Ipp, M., Kooh, S. W., & Cytrynbaum, C. (1997). Velocardiofacial syndrome presenting as hypocalcemia in early adolescence. Archives of Pediatrics & Adolescent Medicine, 151, 745–747.
Thomas, J. A., & Graham, J. M. J. (1997). Chromosome 22q11 Deletion Syndrome: an update and review for the primary pedicatrician. Clinical Pediatrics, 36, 253–266.
Acknowledgments
The authors thank all the participants in the study, and Monica Torsan and Gladys Wong for assistance with preparing the manuscript. This work was supported by a Canadian Institutes of Health Research grant (MOP-97800) a Canada Research Chair in Schizophrenia Genetics and Genomic Disorders (ASB), and Restracomp, Hospital for Sick Children.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martin, N., Mikhaelian, M., Cytrynbaum, C. et al. 22q11.2 Deletion Syndrome: Attitudes towards Disclosing the Risk of Psychiatric Illness. J Genet Counsel 21, 825–834 (2012). https://doi.org/10.1007/s10897-012-9517-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-012-9517-7